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Adverse childhood experiences, DNA
methylation age acceleration, and cortisol
in UK children: a prospective population-
based cohort study
Rosalind Tang1,2*, Laura D. Howe3, Matthew Suderman3, Caroline L. Relton3, Andrew A. Crawford3,4† and
Lotte C. Houtepen3†
Abstract
Background: Epigenetic mechanisms may partly explain the persistent effects of adverse childhood experiences
(ACEs) on health outcomes in later life. DNA methylation can predict chronological age, and advanced methylation-
predicted age beyond chronological age (DNA methylation age acceleration) is associated with ACEs, adverse
mental and physical health, and elevated diurnal and baseline salivary cortisol. Childhood adversity is also
associated with dysregulation of the hypothalamic-pituitary-adrenal axis, which produces the neuroendocrine
hormone cortisol. It remains unknown whether these associations are specific to certain types of adversity. Herein,
we investigate the associations of ACEs with DNA methylation age acceleration and plasma cortisol in the Avon
Longitudinal Study of Parents and Children (ALSPAC) birth cohort.
Methods: In this study of the children in ALSPAC, we used multiple linear regression to examine associations of
cumulative exposure to ACE, as well as exposure to ten individual types of ACEs, with Horvath-estimated DNA
methylation age acceleration and with baseline plasma cortisol. The ten ACEs were those included in the World
Health Organization’s ACE International Questionnaire. Data on ACEs were prospectively collected from age 0–14
years. DNA methylation age acceleration and plasma cortisol were measured at mean 17.1 years and 15.5 years,
respectively.
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Results: We included 974 UK children in the present study. Exposure to four or more ACEs compared to zero was
associated with DNA methylation age acceleration in girls (β, 95% CI = 1.65, 0.25 to 3.04 years) but not in boys (β,
95% CI = − 0.11, − 1.48 to 1.26 years). Also, in girls, emotional abuse and physical abuse were each associated with
DNA methylation age acceleration (β, 95% CI = 1.20, 0.15 to 2.26 years and β, 95% CI = 1.22, 0.06 to 2.38 years,
respectively). No other ACEs were associated with accelerated DNA methylation age in either sex. Associations were
also null between ACE and cortisol, and cortisol and DNA methylation age acceleration.
Conclusions: In this prospective population-based study of UK children, cumulative ACE exposure, emotional
abuse, and physical abuse between age 0 and 14 years were each associated with Horvath-estimated DNA
methylation age acceleration at age 17 years in girls but not in boys.
Keywords: Adversity, Adverse childhood experiences, Child abuse, DNA methylation, Emotional abuse, Epigenetics,
Longitudinal studies
Background
While there is a large body of evidence documenting the
long-term consequences of adverse childhood experi-
ences (ACEs) on social and health outcomes in later life
[1, 2], the mechanisms through which they occur remain
unclear. Epigenetic mechanisms may help to explain the
lasting effects of early life adversity [3]. “Epigenetic
clocks,” which are sets of DNA methylation (DNAm)
markers (CpG sites) that accurately predict chrono-
logical aging, have been recently described [4–6], and
higher DNAm-predicted age relative to chronological
age [DNAm age acceleration (AA)] is associated with
cardiovascular disease [7], cancer [8], lower verbal flu-
ency [9], and all-cause mortality [10]. DNAm AA has
also been associated with childhood exposure to adver-
sity, including parental depression [11], violence [12, 13],
sexual abuse [14], low socioeconomic status [15–17],
and cumulative exposure to sexual abuse, physical abuse,
or neglect [18].
Dysregulation of the hypothalamic-pituitary-adrenal
(HPA) axis is a potential mediator between childhood
adversity, epigenetics, and poor health in later life. Re-
searchers have reported altered HPA axis function and
altered cortisol stress response in adult survivors of
childhood abuse, trauma, and neglect [19]. DNAm AA is
also associated with elevated diurnal [20] and baseline
[21] salivary cortisol in adolescents. Here, we investigate
the associations of individual types of ACEs, as well as
cumulative ACE exposure, with DNAm AA and plasma
cortisol in the Avon Longitudinal Study of Parents and
Children (ALSPAC) birth cohort.
Results
In ALSPAC, 974 children had DNAm measured at
age 17 years, and we included these children in all
analyses (Fig. 1). Baseline characteristics are reported
in Table 1. A comparison of these children and the
rest of the ALSPAC cohort is reported in Additional
file 1: Table S1.
We found no evidence of association between ACE
and DNAm AA when analyzing boys and girls together
(Additional file 1: Table S2). However, we observed sex
interactions in all regression models (Additional file 1:
Table S2 and Additional file 1: Table S3). Table 2 shows
the sex-stratified associations of ACE and DNAm AA.
Exposure to four or more ACEs compared to zero was
associated with DNAm AA in girls (Table 2 and Fig. 2).
The adjusted mean differences in DNAm AA (95% con-
fidence interval (CI)) among girls were 0.32 (− 0.81,
1.45) years for an ACE count of one, 0.68 (− 0.42, 1.78)
years for an ACE count of two or three, and 1.65 (0.25,
3.04) years for an ACE count of four or more when
compared to zero. In our analyses of individual types of
adversity, emotional abuse and physical abuse were each
associated with DNAm AA in girls (Table 2). The ad-
justed mean differences in DNAm AA (95% CI) were
1.20 (0.15, 2.26) years for emotional abuse, and 1.22
(0.06, 2.38) years for physical abuse when compared to
the absence of emotional or physical abuse, respectively.
We found no evidence of association between DNAm
AA and ACE count, or any individual ACE, in boys
(Table 2 and Fig. 2). No associations were consistent be-
tween Horvath (Table 2) and Hannum (Additional file 1:
Table S4) DNAm AA measures.
We found no evidence of associations between any
ACE measures and morning plasma cortisol (Additional
file 1: Table S5). Associations between DNAm AA with
morning plasma cortisol were also null.
Discussion
In this prospective study of 974 UK children, exposure
to four or more ACEs compared to zero was associated
with positive Horvath DNAm AA in girls only. Also in
girls, emotional abuse and physical abuse were each as-
sociated with positive Horvath DNAm AA. This suggests
that exposure to certain types of childhood adversity is
related to accelerated DNA methylation aging in girls.
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Two previous studies examined the association be-
tween cumulative exposure to childhood adversity and
Horvath-estimated DNAm AA [13, 18]. In a meta-
analysis, Wolf et al. [18] did not find evidence of an as-
sociation between cumulative ACE exposure measured
using the Childhood Trauma Questionnaire (sexual
abuse, physical abuse, and physical neglect items only),
nor the Traumatic Life Events Questionnaire (childhood
items only), with Horvath DNAm AA. What may con-
tribute to this difference in findings is the exposure
measure. Wolf et al. [18] used retrospective self-
administered questionnaires, thus relying on one source
and reporting at a single time point, whereas we used a
variety of measures reported by the child and mother at
multiple time points.
The other study investigating cumulative exposure to
childhood adversity and Horvath DNAm AA [13] did re-
port an association between DNAm AA and cumulative
childhood exposure to threat, but not exposure to
deprivation. The threat metric used by Sumner et al.
[13] included emotional abuse, sexual abuse, physical
abuse, domestic violence, and interpersonal violence,
while their deprivation metric included emotional neg-
lect, physical neglect, food insecurity, and/or cognitive
deprivation. Thus, the threat metric includes both emo-
tional abuse and physical abuse, the two ACEs that ap-
pear to drive the association between our cumulative
ACE measure and Horvath DNAm AA in girls. Interest-
ingly, no previous study performed sex-stratified ana-
lyses, despite Sumner et al. [13] identifying a sex
difference in DNAm AA. Numerous other studies also
describe sex differences in DNAm AA [5, 11, 13, 18, 22–
24]. Other key differences between the two previous
studies and the present study include examining individ-
ual types of adversity, prospective reporting of ACE ex-
posure, and data reporting from multiple sources.
Several reports have examined the association between
Horvath DNAm AA and individual types of ACEs [11–
Fig. 1 Flowchart of study population. ALSPAC, Avon Longitudinal Study of Parents and Children; ARIES, Accessible Resource for Integrated
Epigenomic Studies
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18, 25], although few studies use prospectively collected
ACE data [11, 25]. Brody et al. [11] reported a positive
association between primary caregivers’ (91.5% mothers’)
self-reported depressive symptoms when their children
were age 11 years and the children’s Horvath DNAm AA
at age 20 years. Using a cutoff score of 16 on the Center
for Epidemiologic Studies Depression Scale, Brody et al.
[11] categorized caregivers as having higher versus lower
depressive symptoms. In our study, we did not look spe-
cifically at parental depressive symptoms, but instead,
we examined an association between DNAm AA and a
broader measure of parental mental health that also in-
cludes self-harm, attempted suicide, medication for de-
pression, schizophrenia, eating disorders, medication for
anxiety, and hospital admission for any type of mental
health issue. We did not find evidence of an association
between this broader measure of mental health and
DNAm AA. Another study using ALSPAC data exam-
ined the association between ACE exposures up to age
7 years and DNAm AA at age 7 years [25]. Marini et al.
[25] reported null associations between Horvath DNAm
AA and physical or emotional abuse, physical or sexual
abuse, maternal psychopathology, and one adult in the
household at this younger age. Our exposures differed
from those of Marini et al. [25], as they did not investi-
gate physical, emotional, and sexual abuse individually,
nor did they investigate cumulative exposure to more
than one type of adversity. In the present study, we in-
cluded seven additional years of ACE data beyond Ma-
rini et al. [25], with a subsequently higher burden of
childhood adversity, and we were able to investigate all
ten types of ACE included in the World Health
Organization (WHO) ACE International Questionnaire
[26]. Studies using retrospectively self-reported ACE
data have estimated positive associations between Hor-
vath DNAm AA and childhood exposure to violence
measured using the Violence Exposure Scale for
Children-Revised [12, 13], as well as childhood exposure
to sexual abuse [14], where we did not find evidence of
such associations in the children of ALSPAC.
Overall, we found greater DNAm AA in boys rela-
tive to girls, which is consistent with most reports
[18], though not all [13]. The differential associations
we estimated between ACE and DNAm AA between
sexes are also consistent with previous reports of sex
differences in the DNAm sites associated with both
childhood adversity and adult body mass index [27]
and consistent with reports of stronger associations
between ACE and adverse mental health in adult
women compared to adult men [28]. Sex differences
in the effect of ACE on DNAm age may help to ex-
plain these lifelong differences.
Table 1 Characteristics of the study population
Characteristics Mean (SE) or % in girls Mean (SE) or % in boys P valuea
N 500 474
Chronological age 17.11 (0.05) 17.16 (0.05) 0.46
DNA methylation age acceleration (years) − 0.24 (0.18) 0.25 (0.17) 0.05
Plasma cortisol (nmol/L) 522.54 (15.99) 465.85 (11.24) < 0.01
Count of adverse childhood experiences 0.85
None 21.5 22.0
One 24.4 25.9
Two or three 35.9 32.7
Four or more 18.2 19.4
Individual adverse childhood experience exposure
Bullying 14.4 17.1 0.26
Emotional abuse 22.9 21.9 0.75
Emotional neglect 14.6 16.9 0.34
Parent mental health problem 52.7 47.2 0.13
Parent convicted 13.1 11.6 0.60
Parental separation 20.9 25.9 0.11
Physical abuse 18.0 17.8 0.95
Sexual abuse 4.9 2.0 0.05
Household substance abuse 13.4 13.9 0.85
Violence in household 21.3 21.9 0.85
SE standard error
aTwo-tailed P value
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We set out to examine the bidirectional effects of cor-
tisol and DNAm AA following childhood adversity, but
we did not pursue this line of enquiry because we found
no evidence of association between ACE and baseline
plasma cortisol at age 15 years. The cortisol system is
highly complex and dynamic; therefore, further research
using other measures for cortisol, such as a dynamic
measure of cortisol, is needed to further examine the
role of cortisol in the relationship between childhood ad-
versity and DNAm AA.
Strengths of this study include the prospective design
and reporting of childhood adversity from multiple
sources. Due to the sensitive nature of the ACEs, under-
reporting remains likely and there is a high proportion
of missing data in our non-imputed dataset. This likely
contributed to the higher estimates of ACE exposure in
our imputed data compared to our non-imputed data
(Additional file 1: Tables S6-S8). However, our imputed
estimates of ACE count, as well as individual types of
ACE, were similar to those reported in other population-
based birth cohorts including the UK Environmental Risk
Longitudinal Twin Study [29], the Growing Up in
Scotland Birth Cohort 1 [30], the New Zealand Dunedin
cohort [31], the Australian Temperament Project [32],
and the most recent birth cohort in the CDC-Kaiser ACE
Study [33]. The one exception was exposure to parent
mental health problem (52.7% in girls and 47.2% in boys),
which was higher compared to most other studies of
ACEs although still in line with lifetime mental health
prevalence estimates in the USA [34] and in Northern
Ireland [35]. The high proportion of missing data in
ALSPAC arises due to the derivation of ACE measures
using 485 separate questionnaire items spanning 14 years
of data collection from multiple respondents. While only
35 participants met our definition of a complete case (i.e.,
having ≥ 50% complete data for every ACE type), the ma-
jority of participants did contribute a significant amount
of data to the imputation models. Previous research using
these data has also confirmed expected and established re-
lationships between exposure to ACE and outcomes such
as depression, substance misuse, and educational attain-
ment [36]. The Accessible Resource for Integrated Epige-
nomic Studies (ARIES) subset included any mother-child
pairs in ALSPAC with maternal DNA samples available
from two time points (antenatal clinic and follow-up clinic
at child’s mean age 15.5 years) as well as child’s DNA sam-
ples available from three time points (birth, child’s mean
age 7.5 years, and child’s mean age 15.5 years) [37]. This
subset experienced greater cumulative exposure to ACE
and greater individual exposure to emotional neglect or
parental conviction when compared to the remaining chil-
dren in ALSPAC (Additional file 1: Table S1). The chil-
dren in ARIES were also more often White and more
affluent, and we cannot exclude the effect of residual
Table 2 Adverse childhood experience and DNA methylation age acceleration
Exposure Unadjusted mean difference in DNA methylation age
acceleration, years (± 95% CI)
Adjusteda mean difference in DNA methylation age
acceleration, years (± 95% CI)
Girls Boys Girls Boys
Count of ACEs
None 0 0 0 0
One 0.26 (− 0.86, 1.39) − 0.75 (− 1.79, 0.28) 0.32 (− 0.81, 1.45) − 0.48 (− 1.56, 0.60)
Two or three 0.69 (− 0.35, 1.73) − 0.75 (− 1.73, 0.23) 0.68 (− 0.42, 1.78) − 0.30 (− 1.37, 0.78)
Four or more 1.65 (0.40, 2.89)b − 0.51 (− 1.64, 0.63) 1.65 (0.25, 3.04)b − 0.11 (− 1.48, 1.26)
Individual ACE exposure
Bullying 0.42 (− 0.63, 1.47) − 0.77 (− 1.70, 0.16) 0.30 (− 0.79, 1.39) − 0.61 (− 1.63, 0.40)
Emotional abuse 0.96 (− 0.01, 1.94) − 0.49 (− 1.40, 0.42) 1.20 (0.15, 2.26)b − 0.31 (− 1.34, 0.71)
Emotional neglect − 0.23 (− 1.24, 0.79) 0.77 (− 0.14, 1.68) − 0.45 (− 1.53, 0.64) 0.31 (− 0.69, 1.30)
Parent mental health problem 0.92 (0.11, 1.73)b − 0.60 (− 1.34, 0.13) 0.91 (− 0.01, 1.83) − 0.21 (− 1.05, 0.64)
Parent convicted 0.95 (− 0.40, 2.30) − 0.12 (− 1.37, 1.13) 0.56 (− 1.00, 2.12) − 0.15 (− 1.51, 1.21)
Parental separation 0.85 (− 0.15, 1.86) 0.19 (− 0.63, 1.02) 0.90 (− 0.29, 2.10) 0.62 (− 0.34, 1.58)
Physical abuse 1.29 (0.18, 2.41)b − 0.05 (− 1.07, 0.97) 1.22 (0.06, 2.38)b 0.04 (− 1.11, 1.19)
Sexual abuse 1.04 (− 0.84, 2.92) − 0.48 (− 3.17, 2.20) 1.29 (− 0.71, 3.30) − 0.75 (− 3.67, 2.17)
Household substance abuse 0.82 (− 0.52, 2.16) 0.36 (− 0.71, 1.44) 0.72 (− 0.78, 2.22) 0.43 (− 0.78, 1.65)
Violence in household 0.19 (− 0.82, 1.20) 0.26 (− 0.69, 1.20) − 0.15 (− 1.28, 0.99) 0.72 (− 0.35, 1.79)
95% CI 95% confidence interval, ACE adverse childhood experience
aAdjusted for white blood cell composition, smoking status, maternal body mass index, maternal smoking, maternal age at delivery, maternal depression, partner’s
depression, mother’s highest education qualification, household’s highest socioeconomic class
bTwo-tailed P value < 0.05
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selection bias, although this would more likely lead to an
under-estimate of ACE exposure.
Conclusions
Cumulative ACE exposure and exposure to emotional
abuse or physical abuse from age 0 to 14 years are posi-
tively associated with Horvath DNAm AA in girls but
not boys at age 17 years. These findings suggest differen-
tial effects of childhood adversity on DNAm AA be-
tween sexes.
Methods
Participants
ALSPAC is a population-based cohort study which re-
cruited 14,541 pregnant women with expected delivery
dates from 1 April 1991 to 31 December 1992 in Avon,
UK [38, 39]. A total of 14,899 children alive at 1 year
were included [38, 39]. Data collection in the mothers,
mothers’ partners, and children is ongoing via clinic
visits, questionnaires, and data linkages to external orga-
nizations. The ALSPAC website contains details of all
available data through a fully searchable data dictionary
and variable search tool [40]. A sub-study of ALSPAC,
the ARIES subset, was established to study epigenetics
and health [37]. In ARIES, DNAm samples were col-
lected in a subset of 1018 mother-child pairs. In the
present study, we included any child in ARIES who had
epigenome-wide DNAm measured at their adolescence
clinic visit (mean age 17.1 years).
Measures
Both ALSPAC participants themselves and their mothers
reported on multiple forms of ACE at multiple time
points. Full details of the derivation of ACE measures
have been described elsewhere [41]. Briefly, dichotomous
constructs indicating exposure to adversities between
birth and 14 years were created for the ten ACEs that
are included in the WHO ACE International Question-
naire [26]. These ten ACEs are bullying, emotional
abuse, emotional neglect, parental mental illness or sui-
cide attempt, parental criminal conviction, parental sep-
aration, physical abuse, sexual abuse, parental substance
abuse, and violence between parents. How we define
each type of adversity is described in Additional file 1:
Table S9. Most ACE data were collected prospectively,
but some (in particular, sexual abuse) included retro-
spective reports. The ACE data used in the present study
(Table 1) differ from those reported in the data note by
Fig. 2 Cumulative exposure to adverse childhood experiences from age 0–14 years and DNA methylation age acceleration at age 17 years. DNAm
AA, Horvath-estimated DNA methylation age acceleration; ACE, adverse childhood experiences. Scatter plots show mean differences in DNAm AA
for each category of ACE exposure when compared to zero exposure to ACE. Whiskers show 95% confidence intervals. aAdjusted for white blood
cell composition, smoking status, maternal body mass index, maternal smoking, maternal age at delivery, maternal depression, partner’s
depression, mother’s highest education qualification, household’s highest socioeconomic class
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Houtepen et al. [41] because we used a smaller subset of
the ALSPAC cohort; we defined our exposure period as
age 0–14 years rather than 0–16 years because plasma
cortisol was measured at target age 15.5 years, and our
imputation model included additional covariates re-
quired for our regression analyses. Overall, the preva-
lence estimates in our imputed data were similar to that
in the original data note [41].
Peripheral blood was collected at mean age 17.1 years
in ARIES, and DNAm was quantified using Illumina
Infinium HumanMethylation450K BeadChip assay (Illu-
mina Inc., San Diego, CA) as previously described by
Relton et al. [37]. DNAm AA was calculated as the re-
siduals from regression of DNAm age on chronological
age. We describe a positive DNAm age residual as
DNAm AA and a negative residual as DNAm age decel-
eration. Most studies of ACE and DNAm AA use the
Horvath, rather than Hannum, epigenetic clock [11–14,
17]. The Horvath method has been validated in different
tissue types and in samples from children and adults
[42], whereas the Hannum clock was developed using
adult whole blood samples [5]. However, a recent meta-
analysis by Wolf et al. [18] reported a positive associ-
ation between cumulative ACE count and Hannum
DNAm AA but null association with Horvath DNAm
AA. Thus, for completeness, we examine ACE with Hor-
vath estimates in our main analyses and with Hannum
estimates in Additional file 1: Table S4.
Plasma cortisol was measured by radioimmunoassay in
another subset of ALSPAC children with the target age
of 15.5 years. Of the 9985 children invited, 5198
attended (response rate 52%). An additional 55 children
attended after further outreach. Morning cortisol mea-
surements were available in 1567 children though not all
of these children were included in the present study, i.e.,
those who did not have DNAm quantified at age 17
years were not included (Fig. 1).
Statistical analyses
The ACE measures were derived from multiple ques-
tionnaires and clinics over a long time period (birth to
age 14 years). No participants had data on all of the indi-
vidual questionnaire items (> 500 separate questions re-
lating to ACE), necessitating the use of multivariate
multiple imputation to avoid exclusion of participants,
minimize selection bias, and account for missing data.
We derived a dichotomous construct indicating presence
or absence of each ACE if a participant responded to ≥
50% of the questions related to a given ACE. If the par-
ticipant responded to < 50% of the questions for a given
ACE, we set the dichotomous indicator to missing. Of
the 974 participants with DNA methylation measured at
age 17 years, 35 met our definition of a complete case (≥
50% of questions for each ACE). Variables included in
our imputation model were those in our analyses (expo-
sures, covariates, outcomes) or predictors of missingness.
Predictors of missingness are auxiliary variables selected
to inform the generation of unbiased estimates of miss-
ing values and to improve the missing at random as-
sumption [43]. We included twelve auxiliary variables
from the mothers’ and partners’ social history during
pregnancy and nine auxiliary childhood adversity expo-
sures not part of the WHO ACE International Question-
naire. The distribution of all variables in the imputation
model is listed in Additional file 1: Table S10, and how
they were included in the model are reported in Add-
itional file 1: Table S11. Sex differences in DNAm age
and AA have been described in ALSPAC [23] and other
cohorts [5, 11, 13, 18, 22, 24]. To allow for sex-stratified
analyses, imputation was performed separately in male
and female participants, with imputed datasets subse-
quently appended. Additional file 1: Table S6 compares
the distribution of variables in the non-imputed and im-
puted datasets. Additional file 1: Table S7 (girls) and
Additional file 1: Table S8 (boys) separate these distribu-
tions by sex. The complete cases were more affluent
than the full cohort, and a complete case analysis may
have resulted in selection bias. Imputed estimates were
combined using Rubin’s rules [44]. Likelihood-ratio tests
for sex interaction were analyzed using Meng-Rubin’s
rules [45].
We used multiple linear regression to examine associa-
tions of cumulative ACE count and exposure to individ-
ual ACEs with DNAm AA. Covariates were selected in a
stepwise process, where potential confounders were indi-
vidually added and subsequently removed if no effect on
the model was observed. Models were analyzed un-
adjusted and then adjusted for white blood cell compos-
ition, smoking status at time of DNAm measurement,
ethnicity, birth weight, gestational age at delivery, and
maternal variables (smoking, pre-pregnancy weight, body
mass index, home ownership status, age at delivery, par-
ity, marital status, highest educational qualification,
homelessness, Edinburgh Postnatal Depression Scale
(EPDS) at 18 weeks and 32 weeks gestation, partner’s
EPDS at 18 weeks gestation and household’s highest so-
cioeconomic class at 18 weeks gestation). Body mass
index may be a confounder or a mediator in the associ-
ation between childhood adversity and DNAm AA [46].
To avoid over-adjustment, we excluded body mass index
from our main analyses (Table 2), and the associations
with further adjustment for body mass index are re-
ported in Additional file 1: Table S12. The associations
between exposure to childhood adversity and DNAm
AA were similar with and without further adjustment
for body mass index. Similar analyses using multiple lin-
ear regression were performed to investigate associations
of ACE with cortisol, adjusting for cortisol sampling
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time, body mass index, and the same set of covariates as
the DNAm AA analyses with the exclusion of white
blood cell composition and child’s smoking status. Re-
gression models were sex-stratified if an interaction was
identified by likelihood-ratio test using Meng-Rubin’s
rules [45]. All analyses were performed using Stata 15/
MP (StataCorp, Austin, USA).
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s13148-020-00844-2.
Additional file 1:. Supplementary tables.
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